These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. COMPLICATIONS OF THERAPY WITH ORAL HYPOGLYCEMIC AGENTS. BALL JE; LUPIN AM; MARY CC; ELLIOT W J La State Med Soc; 1964 Oct; 116():353-6. PubMed ID: 14200369 [No Abstract] [Full Text] [Related]
4. HYPOGLYCEMIC COMA DURING SULFONYLUREA THERAPY. BERGMAN H Acta Med Scand; 1965 Mar; 177():287-98. PubMed ID: 14281786 [No Abstract] [Full Text] [Related]
5. ORAL MEDICATION IN DIABETES. SCHUSTER F J Am Inst Homeopath; 1964; 57():241-6. PubMed ID: 14216362 [No Abstract] [Full Text] [Related]
6. A SURVEY OF CURRENT THERAPY OF DIABETES MELLITUS. BEASER SB Diabetes; 1964; 13():472-8. PubMed ID: 14206339 [No Abstract] [Full Text] [Related]
7. [SIDE-EFFECTS IN THE ORAL TREATMENT OF DIABETES WITH SULFONYLUREAS]. OSTMAN J; GROENBERG A Nord Med; 1964 Nov; 72():1388-95. PubMed ID: 14210083 [No Abstract] [Full Text] [Related]
8. HYPOTHYROIDISM IN DIABETICS TREATED WITH SULPHONYLUREA. HUNTON RB; WELLS MV; SKIPPER EW Lancet; 1965 Sep; 2(7410):449-51. PubMed ID: 14337821 [No Abstract] [Full Text] [Related]
9. HYPOGLYCEMIA IN TOLBUTAMIDE-TREATED DIABETES; REPORT OF TWO CASES WITH MEASUREMENT OF SERUM INSULIN. SOELDNER JS; STEINKE J JAMA; 1965 Aug; 193():398-9. PubMed ID: 14313905 [No Abstract] [Full Text] [Related]
10. [OUR EXPERIENCES WITH ORAL ANTIDIABETICS IN OUTPATIENT CONTROL AND TREATMENT OF DIABETIC PATIENTS]. ANGELI I Orv Hetil; 1964 Nov; 105():2186-90. PubMed ID: 14216805 [No Abstract] [Full Text] [Related]
12. DIABETES AND NEUROPATHY. LEWIS GW Br Med J; 1964 Nov; 2(5420):1330-1. PubMed ID: 14201227 [No Abstract] [Full Text] [Related]
13. ORAL HYPOGLYCEMIC DRUGS: COMPARATIVE EVALUATION OF TOLBUTAMIDE, CHLORPROPAMIDE AND PHENFORMIN. MOSS JM; DELAWTER DE; GALLAGHER EJ Med Times; 1964 Jul; 92():645-54. PubMed ID: 14184191 [No Abstract] [Full Text] [Related]
14. THE FAMILY DOCTOR AND THE DIABETIC. KEEN H Practitioner; 1965 Feb; 194():244-9. PubMed ID: 14259709 [No Abstract] [Full Text] [Related]
15. CHOLESTATIC JAUNDICE FOLLOWING USE OF SULFONYLUREA DRUGS. COLLENS WS; DOBKIN GB N Y State J Med; 1965 Apr; 65():907-9. PubMed ID: 14265335 [No Abstract] [Full Text] [Related]
16. TREATMENT OF DIABETIC PATIENTS WITH CHLORPROPAMID AFTER SECONDARY FAILURE ON TOLBUTAMIDE. TITTLE CR; KERR JH Curr Ther Res Clin Exp; 1965 May; 7():297-303. PubMed ID: 14286209 [No Abstract] [Full Text] [Related]
17. SEVERE AND PROLONGED HYPOGLYCEMIC SHOCK DURING SULFONYLUREA TREATMENT. BAUER HG Metabolism; 1965 Mar; 14():220-8. PubMed ID: 14261406 [No Abstract] [Full Text] [Related]
18. THE ORAL HYPOGLYCEMIC COMPOUNDS. FERGUSON BD Med Clin North Am; 1965 Jul; 49():929-38. PubMed ID: 14300336 [No Abstract] [Full Text] [Related]
19. [2 CASES OF HYPOGLYCEMIA DUE TO CHLORPROPAMIDE IN DIABETIC SUBJECTS]. CONTE M; FOUET P; LIGUORY C Bull Mem Soc Med Hop Paris; 1965 Feb; 116():467-71. PubMed ID: 14308217 [No Abstract] [Full Text] [Related]
20. SEVERE HYPOGLYCEMIA INDUCED BY CHLORPROPAMIDE IN A NON-DIABETIC. DELVECCHIO PJ J Med Soc N J; 1965 Sep; 62():443-5. PubMed ID: 14341101 [No Abstract] [Full Text] [Related] [Next] [New Search]